Mangalam Drugs & Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve Prior Intimation ....

Mangalam Drugs and Organics Limited ‘ AR MANGALAM Regd: Office : Rupam Building, 3rd Floor, 239 P. D’Mello Road, NearG. P. 0. Mumbai - 4000?: ® 91-22-62616/ 2630000 / 8787 @ 91-22-62619090 e CIN : L24230MH1972PI C116413 August 05, 2026 REF: MDOL/CS-SE/2026-27/019 Listing Department Listing Department National Stock Exchange of India BSE Ltd 1st Floor, New Trade Wing, Limited Phiroze Jeejeebhoy Towers, “Exchange Plaza”, 5% Floor, Plot No. C-1, Block G, Dalal Street, Fort, Mumbai - 400 001 Bandra - Kurla Complex, Bandra(E), Mumbai - 400 051 Scrip Code: 532637 Symbol: MANGALAM Subject: Mangal. ics Limi m| ”- Prior Intimation of Board Meetintgo be held on Wednesday, August 12th, 2026 Dear Sir/Madam, Pursuant to Regulation 29 and other applicable provisions, if any, of the Securities and Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015, we are pleased to inform that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, August 12th, 2026 at the registered office of the Company situated at 3¢ Floor, Rupam Building, 239, P. D’'Mello Road, Near G.P.0., Mumbai, Maharashtra-400001 inter-alia to consider the following businesses enunciated as under: 01) To consider, approve and take on record the Un-Audited Financial Results (Standalone & Consolidated) of the Company for the quarter ended June 30, 2026 (“the Financial Results”); 02) To consider and appoint M/s L.N. Joshi & Co. Practicing Company Secretaries (CP No.: 4216), as Secretarial Auditors of the Company for a period of five consecutive years from conclusion of 537 AGM to 58t AGM of the Company, subject to approval of the members at the ensuing 5374 AGM; 03) To consider and appoint M/s S.N. Nanda & Co. Chartered Accountants (FRN:000685N) as Statutory Auditor in place oft he Retiring Statutory Auditor M/s V.S. Somani & Co., Chartered Accountants (FRN: 117589W) upon Completion of their Term. Further, in terms of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, and in accordance with Company’s internal code of conduct for prevention of insider trading, the Trading Window for dealing in the securities of the Company has been closed for Directors / Officers and designated employees of the Company from July 1, 2026 and shall remain closed till the expiry of 48 hours from the Factory : at Vapi (Gujarat) India ® contactus@mangalamdrugs.com @ http://www.mangalamdrugs.com Mangalam Drugs and Organics Limited )@i MANGALAM Regd: Office : R ®u p 9a 1m - B 2u 2il -di 6ng 2, 63 1rd 6/ F 26lo 03o 0r 00, /2 3 89 7 8P. 7 D @'M e 9l 1l -o 2 2R -o 6a 2d 6, 1 N 9e 0a 9r 0 G «. CP. I N0 . : M [u 2m 4b 2a 3i 0 M- H4 10 90 7 0 20 P1 C 116413 W= H OCME \ announcement/ declaration of the Un-audited Financial Results of the Company for the quarter ended June 30, 2026. The closure of Trading Window has been informed to the Designated Persons covered by the Code. Kindly take the above information on your records. Thanking You, Yours Faithfully, For Mangalam Drugs & Organics Limited Govardhan M. Dhoot Managing Director DIN: 01240086 Factory : at Vapi (Gujarat) India & contactus@mangalamdrugs.com @ http://www. mangalamdrugs.com